Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Yau

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
European Journal of Haematology|November 1, 1991
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationJ C Yau, M A Dimopoulos, S D Huan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatinS D Huan, J C Yau, F R Dunphy, et al.
Bone Marrow Transplantation|April 1, 1990
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host diseaseJ C Yau, C F LeMaistre, G K Zagars, et al.
American Journal of Hematology|December 1, 1991
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisoloneJ C Yau, M A Dimopoulos, S D Huan, et al.
American Journal of Hematology|September 1, 1992
Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiationJ C Yau, C F LeMaistre, B S Andersson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Duration of intravenous antibiotics for patients with neutropenic feverA T Tomiak, J C Yau, S D Huan, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinomaJ C Yau, S Z Gertler, J Hanson, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
European Journal of Haematology|November 1, 1991
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationJ C Yau, M A Dimopoulos, S D Huan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatinS D Huan, J C Yau, F R Dunphy, et al.
Bone Marrow Transplantation|April 1, 1990
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host diseaseJ C Yau, C F LeMaistre, G K Zagars, et al.
American Journal of Hematology|December 1, 1991
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisoloneJ C Yau, M A Dimopoulos, S D Huan, et al.
American Journal of Hematology|September 1, 1992
Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiationJ C Yau, C F LeMaistre, B S Andersson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Duration of intravenous antibiotics for patients with neutropenic feverA T Tomiak, J C Yau, S D Huan, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinomaJ C Yau, S Z Gertler, J Hanson, et al.
Pageof 4